These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 22366634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.
    Anastasilakis AD, Polyzos SA, Delaroudis S, Bisbinas I, Sakellariou GT, Gkiomisi A, Papadopoulou E, Gerou S, Makras P.
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):816-22. PubMed ID: 22676573
    [Abstract] [Full Text] [Related]

  • 3. No effect of rosuvastatin in the zoledronate-induced acute-phase response.
    Makras P, Anastasilakis AD, Polyzos SA, Bisbinas I, Sakellariou GT, Papapoulos SE.
    Calcif Tissue Int; 2011 May; 88(5):402-8. PubMed ID: 21305270
    [Abstract] [Full Text] [Related]

  • 4. Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.
    Rossini M, Adami S, Viapiana O, Ortolani R, Vella A, Fracassi E, Gatti D.
    J Bone Miner Res; 2012 Jan; 27(1):227-30. PubMed ID: 21956654
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ACUTE PHASE REACTIONS AFTER ZOLEDRONIC ACID INFUSION: PROTECTIVE ROLE OF 25-HYDROXYVITAMIN D AND PREVIOUS ORAL BISPHOSPHONATE THERAPY.
    Crotti C, Watts NB, De Santis M, Ceribelli A, Fabbriciani G, Cavaciocchi F, Marasini B, Selmi C, Massarotti M.
    Endocr Pract; 2018 May; 24(5):405-410. PubMed ID: 29498910
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.
    Saag K, Lindsay R, Kriegman A, Beamer E, Zhou W.
    Bone; 2007 May; 40(5):1238-43. PubMed ID: 17347063
    [Abstract] [Full Text] [Related]

  • 11. Cytokines and insulin resistance after zoledronic acid-induced acute phase response.
    Kassi G, Papamichael K, Papaioannou G, Giagourta I, Thanou S, Triantaphyllopoulou M, Zapanti E, Papandroulaki F, Ktena V, Karga H.
    Immunol Invest; 2014 May; 43(6):544-55. PubMed ID: 24661204
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH, Oostendorp-van de Ruit M, Van der Pluijm G, Löwik CW, Papapoulos SE.
    J Bone Miner Res; 1995 Jun; 10(6):956-62. PubMed ID: 7572320
    [Abstract] [Full Text] [Related]

  • 13. Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion.
    Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Dalle Carbonare L, Lo Cascio V.
    J Bone Miner Res; 2010 Mar; 25(3):447-54. PubMed ID: 20200999
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
    Silverman SL, Kriegman A, Goncalves J, Kianifard F, Carlson T, Leary E.
    Osteoporos Int; 2011 Aug; 22(8):2337-45. PubMed ID: 21116816
    [Abstract] [Full Text] [Related]

  • 16. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.
    Ding Y, Zeng JC, Yin F, Zhang CL, Zhang Y, Li SX, Liu X, Zhang C, Xue QY, Lin H, Pei FX.
    Orthop Surg; 2017 Aug; 9(3):284-289. PubMed ID: 28960821
    [Abstract] [Full Text] [Related]

  • 17. Acute phase response and mineral status following low dose intravenous zoledronic acid in children.
    Munns CF, Rajab MH, Hong J, Briody J, Högler W, McQuade M, Little DG, Cowell CT.
    Bone; 2007 Sep; 41(3):366-70. PubMed ID: 17574945
    [Abstract] [Full Text] [Related]

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 19. Characterization of and risk factors for the acute-phase response after zoledronic acid.
    Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM.
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4380-7. PubMed ID: 20554708
    [Abstract] [Full Text] [Related]

  • 20. Acute phase response after zoledronic acid is associated with long-term effects on white blood cells.
    Rossini M, Adami S, Viapiana O, Tripi G, Zanotti R, Ortolani R, Vella A, Troplini S, Gatti D.
    Calcif Tissue Int; 2013 Sep; 93(3):249-52. PubMed ID: 23748711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.